At home in Southern Germany, the passionate stock exchange expert has been accompanying the capital markets for about twenty years. With a soft spot for smaller companies, he is constantly on the lookout for exciting investment stories. That it depends thereby less on large names, but on the future potential and whether the market also recognizes these perspectives, was one of its first learnings at the stock exchange.
On these pages, Nico examines current events at listed companies and takes a closer look at companies that are traded under the radar of the market, in addition to well-known securities.
In order to be able to take advantage of speculative opportunities on the stock exchange, Nico not only focuses on a balanced asset allocation of defensive and opportunity-oriented securities, but also on an intact risk management. "In addition to position size and entry in several tranches, investors should also develop a sense of timing and get to know a stock better before investing," says the columnist.
Commented by Nico Popp
Commented by Nico Popp on May 17th, 2022 | 09:54 CEST
Alzheimer's share? Ask the CEO! Valneva, NervGen Pharma, Bayer
High blood pressure, diabetes, stroke and Alzheimer's disease are scourges of our time. As people in industrialized countries grow older, it becomes increasingly likely that they will also suffer from one of these diseases. While there is likely to be a genetic predisposition for all of the ailments mentioned, lifestyle also plays a role. Lack of exercise and obesity often leads first to high blood pressure, then to diabetes, and ultimately to even worse conditions. In the event of a pandemic, all people with such pre-existing conditions belong to a high-risk group. Reason enough to take a closer look at stocks related to these issues and ask how investors can profit.
Read
Commented by Nico Popp on May 16th, 2022 | 12:48 CEST
Future Tech check: BASF, Meta Materials, BYD, Rock Tech Lithium
What will drive share prices in the future is more uncertain than ever. The sword of Damocles of the recession is currently hovering over many future topics. But should long-term investors be driven by fear of recession? On the contrary! Now is the best time to consider investments for the future. The good thing is that thorough due diligence can pay off twice over. First, it increases the chances of hitting the bull's eye, and second, the prices may even suit investors. We take a closer look at three shares!
Read
Commented by Nico Popp on May 9th, 2022 | 12:50 CEST
Progress at any price! Mercedes-Benz, BrainChip, Varta
People want mobility. We cannot convey a future full of renunciation. Instead, sustainable innovations must be made attractive. What sounds like squaring the circle from today's perspective can become a well-rounded affair in the long term - if ideas meet technology. We present three stocks related to the future of mobility and explain where investors can also see the potential.
Read
Commented by Nico Popp on May 5th, 2022 | 11:52 CEST
Biotech-Investments also work conservatively: BioNTech, XPhyto, Valneva
Biotech stocks are often seen as all-or-nothing investments - either a bet works out, or the companies disappear into oblivion. But innovative companies in the pharmaceutical and biotech sectors do not always operate in just one area. They are not always spectacular projects that are dependent on approval procedures. We outline the investment opportunities around three well-known biotech stocks.
Read
Commented by Nico Popp on May 4th, 2022 | 13:05 CEST
Attention, special situation! BASF, Barsele Minerals, Amazon
Old Economy? Tech stocks? Or special situations? Investors find different ways to stay invested during difficult market phases. It is not for nothing that the motto "Time in the market beats timing in the market" exists. Nevertheless, it makes sense right now to increase the equity quota only selectively. We will outline which stocks could be considered for this using three companies as examples.
Read
Commented by Nico Popp on May 3rd, 2022 | 10:41 CEST
Tech stocks - Where is the party over? Alibaba, wallstreet:online, PayPal
For years, digital business models were considered the best of the best. But the past April has punished stocks such as Alibaba and PayPal - in some cases, very significantly. The question now is: Is the age of growth companies coming to an end, or are the current prices possibly a good opportunity? And what other factors might be playing a role?
Read
Commented by Nico Popp on May 2nd, 2022 | 11:32 CEST
Do not ignore ESG risks: Deutsche Bank, Ximen Mining, BYD
ESG is more than electric company cars, a paperless office and avoiding unnecessary air travel. Those who take the third pillar of the ESG approach seriously must also pay attention to good corporate governance. In the criteria of the index and data providers, good "governance" is about, among other things, management structures and sophisticated control instances at the corporate level. We explain why the "G" in ESG can bring tangible benefits to investors and how investors can invest in companies with good ESG criteria.
Read
Commented by Nico Popp on April 29th, 2022 | 06:00 CEST
Interview Phoenix Copper: Copper with certain advantages
Phoenix Copper could go into production as early as 2023 and surprise the market with its production costs and other general conditions. In an interview, CEO Ryan McDermott explains why the Company doesn't believe in making a lot of promises, why the planned Empire Open Pit project doesn't anticipate any environmental impacts, and what other potential lies dormant in the Company.
Read
Commented by Nico Popp on April 28th, 2022 | 11:59 CEST
Never invest like Elon Musk! Twitter, Phoenix Copper, BYD
Data is the raw material of the 21st century. Looking at the war in Ukraine and the pandemic, one could also speak of information as an important raw material. After all, data has to be interpreted. In a world that is becoming increasingly complex, some data can be used to draw different and sometimes contradictory conclusions. That makes it all the more important for data to become information and for competent experts to interpret data. Elon Musk's acquisition of Twitter is expected to encourage this. But what does this mean for investors?
Read
Commented by Nico Popp on April 27th, 2022 | 11:54 CEST
Where the sentiment is right: BioNTech, Defence Therapeutics, Amazon
If you want to sell air mattresses in November, you will not succeed even with huge discounts. It is a similar story when selecting stocks. In order to reap returns, investors need to assess the market and bet on the stocks that will be in demand in the near future. In the case of vaccine stocks, the air seemed to be out recently. But now, there are growing indications that more vaccine doses may be needed. We take a look at the sentiment of three stocks.
Read